|Articles|March 17, 2010
Supplements and Featured Publications
- Implications of Early Treatment for Parkinson’s Disease [CME/CPE]
- Volume 16
- Issue 4
Posttest: Implications of Early Treatment for Parkinson's Disease
Advertisement
Instructions
After reading “Implications of Early Treatment for Parkinson’s Disease,” complete the program evaluation and select the 1 best answer to each of the following questions.
A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.
Articles in this issue
over 16 years ago
Participating Facultyover 16 years ago
Early Pharmacologic Treatment in Parkinson's DiseaseAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Medicaid MFN Pricing Could Save $8.6 Billion
2
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
3
Active US Drug Shortages Rise for Third Straight Quarter
4
Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD
5